je.st
news
Daiichi Sankyo in Clot-Drug Race With Edoxaban Study Success
2013-09-02 14:15:57| Biotech - Topix.net
Daiichi Sankyo Co.' s experimental blood thinner edoxaban was found to be as effective and safer than standard treatment warfarin in a study that clears the way for the Japanese company to compete with drugmakers including Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Co.
Tags: study
success
race
sankyo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||